Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report

Congenital generalized lipodystrophy type 4 (CGL4) is a rare disease caused by mutations in the gene polymerase I and transcript release factor (PTRF), the main symptoms of which are systemic reductions in adipose tissue and muscular dystrophy. The strategy of treating CGL4 is to improve the insulin...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Pediatr Endocrinol
Главные авторы: Takeyari, Shinji, Takakuwa, Satoshi, Miyata, Kei, Yamamoto, Kenichi, Nakayama, Hirofumi, Ohata, Yasuhisa, Fujiwara, Makoto, Kitaoka, Taichi, Kubota, Takuo, Namba, Noriyuki, Sakai, Norio, Ozono, Keiichi
Формат: Artigo
Язык:Inglês
Опубликовано: The Japanese Society for Pediatric Endocrinology 2019
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6356095/
https://ncbi.nlm.nih.gov/pubmed/30745727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.28.1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы